ZERBE ROBERT L MD 4
4 · Vericel Corp · Filed Nov 25, 2024
Insider Transaction Report
Form 4
Vericel CorpVCEL
ZERBE ROBERT L MD
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-11-22+2,500→ 10,000 totalExercise: $13.05Exp: 2028-05-02→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2024-11-22$13.05/sh+2,500$32,625→ 29,095 total - Sale
Common Stock
2024-11-22$60.00/sh−2,500$150,000→ 26,595 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2024.
- [F2]These options, representing the right to purchase 17,500 shares, were originally granted on May 2, 2018, becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from June 2, 2018 through May 2, 2019.